One of the rare but serious risks is pancreatitis (inflammation of the pancreas), which may lead to severe stomach pain, fever, or vomiting that does not go away
Zepbound is FDA-approved for two indications: chronic weight management in adults with obesity (BMI 30) or overweight (BMI 27) with a weight-related condition (November 2023), and obstructive sleep apnea in adults with obesity (December 2024, based on SURMOUNT-OSA)
Food and Drug Administration for the treatment of chronic weight management in those with obesity or overweight who have at least one weight-related condition
2019), mice fed a high-fat and high-cholesterol diet (Liu et al
In studies , some people whose blood sugars were controlled on semaglutide saw their prediabetes or diabetes get worse after stopping semaglutide
Most cognitive peptides target neurotransmitter systems or general neurotrophic support